S. Fleming

1.7k total citations
59 papers, 1.3k citations indexed

About

S. Fleming is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Fleming has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in S. Fleming's work include Renal and related cancers (22 papers), Renal cell carcinoma treatment (15 papers) and Renal Diseases and Glomerulopathies (7 papers). S. Fleming is often cited by papers focused on Renal and related cancers (22 papers), Renal cell carcinoma treatment (15 papers) and Renal Diseases and Glomerulopathies (7 papers). S. Fleming collaborates with scholars based in United Kingdom, United States and Australia. S. Fleming's co-authors include George B.M. Lindop, Susan Kelly, Kathy Pritchard‐Jones, G. E. Butterfield, J. R. Sutton, David R. Garrod, George A. Brooks, John Τ. Reeves, A. A. M. Gibson and Martin M. Black and has published in prestigious journals such as Development, Journal of Applied Physiology and British Journal of Cancer.

In The Last Decade

S. Fleming

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Fleming United Kingdom 22 687 463 219 166 164 59 1.3k
Mark de Caestecker United States 19 1.4k 2.0× 424 0.9× 207 0.9× 91 0.5× 194 1.2× 25 1.9k
László Hegyi United Kingdom 13 680 1.0× 163 0.4× 204 0.9× 104 0.6× 247 1.5× 23 1.6k
Valentina Câmpean Germany 19 521 0.8× 218 0.5× 189 0.9× 234 1.4× 165 1.0× 30 1.3k
Kiyotaka Nagahama Japan 24 467 0.7× 304 0.7× 117 0.5× 119 0.7× 168 1.0× 83 1.4k
Hisashi Hasumi Japan 20 700 1.0× 697 1.5× 217 1.0× 213 1.3× 145 0.9× 73 1.4k
Masamichi Shiraga Japan 23 401 0.6× 159 0.3× 128 0.6× 82 0.5× 180 1.1× 44 1.6k
Shiying Cui Canada 17 1.2k 1.8× 223 0.5× 318 1.5× 361 2.2× 240 1.5× 24 1.8k
Hiroyuki Kaneto Japan 15 589 0.9× 303 0.7× 66 0.3× 104 0.6× 263 1.6× 47 1.4k
Deepa Shukla United Kingdom 15 667 1.0× 207 0.4× 196 0.9× 557 3.4× 172 1.0× 22 1.2k
Kameswaran Surendran United States 19 1.1k 1.7× 308 0.7× 360 1.6× 89 0.5× 200 1.2× 28 1.6k

Countries citing papers authored by S. Fleming

Since Specialization
Citations

This map shows the geographic impact of S. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fleming more than expected).

Fields of papers citing papers by S. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fleming. The network helps show where S. Fleming may publish in the future.

Co-authorship network of co-authors of S. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of S. Fleming. A scholar is included among the top collaborators of S. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Fleming. S. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, S., et al.. (2025). A case of chronic myelomonocytic related lysozyme-induced nephropathy. BMC Nephrology. 26(1). 302–302.
2.
Asif, Aqua, et al.. (2024). Today's surgeons: are we cutting edge or are we being forced to cut corners?. Bulletin of The Royal College of Surgeons of England. 106(2). 106–109.
3.
Jakes, Adam D, Madhav C. Menon, Kate Adams, et al.. (2016). Renal Squamous Cell Carcinoma of a Native Kidney After Renal Transplant: A Case Report. Transplantation Proceedings. 48(1). 259–261. 2 indexed citations
4.
Fitzpatrick, Patricia, Petra Rauchhaus, Joan Cunningham, et al.. (2014). Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery. British Journal of Cancer. 111(7). 1381–1390. 32 indexed citations
5.
Appleyard, M. Virginia C. L., Karen Murray, Philip J. Coates, et al.. (2012). Phenformin as prophylaxis and therapy in breast cancer xenografts. British Journal of Cancer. 106(6). 1117–1122. 89 indexed citations
6.
Fleming, S.. (1999). Renal cancer genetics: von Hippel Lindau and other syndromes. The International Journal of Developmental Biology. 43(5). 469–471. 7 indexed citations
7.
Kotelevtsev, Yuri, R W Brown, S. Fleming, et al.. (1998). Hypertension in mice caused by inactivation of 11 beta-hydroxysteroid dehydrogenase type 2. Journal of Hypertension. 16. 8 indexed citations
8.
O’Donnell, Marie & S. Fleming. (1997). REVIEW The renal pathology of mushroom poisoning. Histopathology. 30(3). 280–282. 11 indexed citations
9.
O’Donnell, Marie & S. Fleming. (1995). Angiomyolipoma of kidney—a cause of recurrent retroperitoneal haemorrhage. British Journal of Urology. 76(4). 521–522. 3 indexed citations
10.
Jenkins, David, Davina Wojtacha, Pamela D. Swan, S. Fleming, & Allan D. Cumming. (1995). Renal Expression of lnterleukin-2 Receptor mRNA in Patients with Crescentic Glomerulonephritis. ˜The œNephron journals/Nephron journals. 71(3). 303–308. 4 indexed citations
11.
Jenkins, David, Davina Wojtacha, Pamela D. Swan, S. Fleming, & Allan D. Cumming. (1994). Intrarenal localization of interleukin-1β mRNA in crescentic glomerulonephritis. Nephrology Dialysis Transplantation. 9(9). 1228–1233. 18 indexed citations
12.
Fleming, S.. (1993). The impact of genetics on the classification of renal carcinoma. Histopathology. 22(1). 89–92. 30 indexed citations
13.
Yau, Joyce L.W., Aernout D. van Haarst, Marie‐Pierre Moisan, et al.. (1991). 11 beta-Hydroxysteroid dehydrogenase mRNA expression in rat kidney. American Journal of Physiology-Renal Physiology. 260(5). F764–F767. 12 indexed citations
14.
Fleming, S.. (1991). Cell adhesion and focusing of inflammatory responses. Histopathology. 19(6). 571–573. 5 indexed citations
15.
Garrod, David R. & S. Fleming. (1990). Early expression of desmosomal components during kidney tubule morphogenesis in human and murine embryos. Development. 108(2). 313–321. 54 indexed citations
16.
Clark, Brian R., Susan Kelly, & S. Fleming. (1990). Calgranulin expression and association with the keratinocyte cytoskeleton. The Journal of Pathology. 160(1). 25–30. 23 indexed citations
17.
Kelly, Susan, Martin M. Black, & S. Fleming. (1989). Pemphigoid gestationis: A unique mechanism of initiation of an autoimmune response by MHC class II molecules?. The Journal of Pathology. 158(1). 81–82. 34 indexed citations
18.
Fleming, S., et al.. (1987). Renal Tubular Antigens in Regenarative Epithelium and Renal Carcinoma. British Journal of Urology. 60(2). 103–109. 11 indexed citations
19.
Fleming, S. & G. E. Brown. (1986). Distribution of fucosylatedN-acetyl lactosamine carbohydrate determinants during embryogenesis of the kidney in man. The Histochemical Journal. 18(2-3). 61–66. 9 indexed citations
20.
Fleming, S., et al.. (1986). Hypoglycaemic coma associated with gastric carcinoma. Postgraduate Medical Journal. 62(730). 761–764. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026